Top Markets
Coin of the day
Eagle Pharmaceuticals, Inc. Eagle Pharmaceuticals, Inc.

Eagle Pharmaceuticals, Inc.

EGRX
Κατάταξη σε μετοχές #33346
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on... Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on manufacturing, developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company’s product portfolio offers RYANODEX for malignant hyperthermia; and BELRAPZO and BENDEKA for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin’s lymphoma. It also produces PEMFEXY, a ready-to-dilute liquid form of pemetrexed injection, indicated in combination with cisplatin for the initial treatment of patients with malignant pleural mesothelioma and non-small cell lung cancer; BARHEMSYS, a selective dopamine-2 (D2) and dopamine-3 (D3) receptor antagonist indicated in adults for prevention of postoperative nausea and vomiting (PONV); BYFAVO, a benzodiazepine indicated for the induction and maintenance of procedural sedation in adults. The company has license and collaboration agreements with Combioxin, SA for the development and commercialization rights to CAL02, an anti-toxin agent in Phase 2 development for the treatment of severe pneumonia in combination with traditional antibacterial drugs; ENA-001 developed by Enalare, an agnostic respiratory stimulant for respiratory depression; EA-114, novel and proprietary formulation of fulvestrant developed for hormone-receptor-positive (HR+) metastatic breast cancer. It has a strategic collaboration with Tyme Technologies, Inc. for the development of SM-88 to treat cancer. Eagle Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Woodcliff Lake, New Jersey.
Τιμή μετοχής
$0.595
Τελευταίος συγχρονισμός: 2026-08-13
Κεφαλαιοποίηση
$7.83M
Αλλαγή (1 ημέρα)
0.00%
Αλλαγή (1 έτος)
-81.41%
Χώρα
US
Εμπόριο Eagle Pharmaceuticals, Inc. (EGRX)

Κατηγορία

Ιστορικό τιμής μετοχής για την Eagle Pharmaceuticals, Inc. (EGRX)
Υψηλότερη τιμή κλεισίματος: $0.27 στις 2026-08-01

Χαμηλότερη τιμή κλεισίματος: $12.89 στις 2014-02-01
Ιστορικό τιμής μετοχής της Eagle Pharmaceuticals, Inc. από 2014 έως 2026
Ετήσια απόδοση τιμής μετοχής
Έτος Απόδοση
2026 (TTM) 96.79%
2025 -29.61%
2024 -87.52%
2023 -82.65%
2022 -38.74%
2021 7.84%
2020 -20.71%
2019 39.37%
2018 -25.22%
2017 -26.15%
2016 -16.70%
2015 591.76%
2014 0.00%
Τιμή μετοχής για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία Τιμή μετοχής Μεταβολή 1Έτ% Χώρα
$171.67 -
DE
$161.26 22.94%
DE
$35.97 20.03%
JP
$222.59 36.04%
CH
$20.77 10.96%
IN